Vantage Investment Partners’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELAN
SCM
BCIM
Vantage Investment Partners's ELAN Position: Q2 2023 in Review
Vantage Investment Partners sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 73,863 shares — an estimated $694K sold.
Vantage Investment Partners first reported a position in ELAN in Q3 2019 and held it in 15 quarters. The position peaked at $222M in Q3 2021. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.
- Vantage Investment Partners reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
- Vantage Investment Partners sold 73,863 Elanco Animal Health shares in Q2 2023, an estimated $694K.
- Vantage Investment Partners first reported a position in Elanco Animal Health in Q3 2019 and held it in 15 quarters.
- Vantage Investment Partners's Elanco Animal Health position peaked at $222M in Q3 2021.
- 352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.
Based on Vantage Investment Partners's 13F filing for Q2 2023, filed 24 Jul 2023.